Subpage under development, new version coming soon!
Subject: Virus cinese 2...Non ci fermerete mai!
More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/add4d744-30da-4df4-b703-80488c1b3104?emailId=600ffed894cc9a000445a348&segmentId=13b7e341-ed02-2b53-e8c0-d9cb59be8b3b
The expansion in trade was fuelled by rising demand for imports in advanced economies. China was the main beneficiary, registering a 5.6 per cent month-on-month growth in exports, but its import volumes fell.
Goods imports rose 3 per cent month on month in the US and 1.9 per cent in the eurozone. China became the EU’s biggest trading partner in the first 11 months of 2020, overtaking the US, separate official data showed.
The improvement in both trade and industrial output came before the fresh upsurge in cases of the virus in several major economies, which has prompted new lockdowns and restrictions on activity and could pose a headwind to the economic recovery.
But global trade is expected to continue to expand in December, according to a survey of manufacturers by IHS Markit which showed an increase in the proportion of global factories which reported improving foreign orders.
Adam Slater, lead economist at Oxford Economics, said that “despite renewed restrictions in a number of economies in recent months, the growth rate of trade in 2021 will be strong”. He expects world trade volumes to expand by around 9 per cent in 2021, after slumping by 7 per cent last year.
But Joanna Konings, senior economist at ING, warned that a shortage of shipping containers and the rising cost of seaborne trade could limit volumes.
The trade data are adjusted for both inflation and seasonality.
si parla di GLOBAL trade, solo i dati provengono dall'Olanda
https://www.ft.com/content/add4d744-30da-4df4-b703-80488c1b3104?emailId=600ffed894cc9a000445a348&segmentId=13b7e341-ed02-2b53-e8c0-d9cb59be8b3b
The expansion in trade was fuelled by rising demand for imports in advanced economies. China was the main beneficiary, registering a 5.6 per cent month-on-month growth in exports, but its import volumes fell.
Goods imports rose 3 per cent month on month in the US and 1.9 per cent in the eurozone. China became the EU’s biggest trading partner in the first 11 months of 2020, overtaking the US, separate official data showed.
The improvement in both trade and industrial output came before the fresh upsurge in cases of the virus in several major economies, which has prompted new lockdowns and restrictions on activity and could pose a headwind to the economic recovery.
But global trade is expected to continue to expand in December, according to a survey of manufacturers by IHS Markit which showed an increase in the proportion of global factories which reported improving foreign orders.
Adam Slater, lead economist at Oxford Economics, said that “despite renewed restrictions in a number of economies in recent months, the growth rate of trade in 2021 will be strong”. He expects world trade volumes to expand by around 9 per cent in 2021, after slumping by 7 per cent last year.
But Joanna Konings, senior economist at ING, warned that a shortage of shipping containers and the rising cost of seaborne trade could limit volumes.
The trade data are adjusted for both inflation and seasonality.
si parla di GLOBAL trade, solo i dati provengono dall'Olanda
Non vedo la Francia...
France | 1,092,958 | 1.6 | Jan 25 2021
France | 1,092,958 | 1.6 | Jan 25 2021
mi dicono parenti inglesi appena vaccinati che da loro il richiamo è previsto dopo 3 mesi
ma che diavoleria è questa???? Jaime, conferma? Trattasi di vaccino diverso?
(edited)
ma che diavoleria è questa???? Jaime, conferma? Trattasi di vaccino diverso?
(edited)
Terzo e Quarto mondo dovranno aspettare i saldi... a volte a chi auspica che "l'umanità scompaia" si debbono riconoscere buoni argomenti
(edited)
(edited)
Di questo passo...di certo l’evoluzione non sarà una certezza
. The expansion in trade was fuelled by rising demand for imports in advanced economies. China was the main beneficiary, registering a 5.6 per cent month-on-month growth in exports, but its import volumes fell.
Dixit
Dixit
mi dicono parenti inglesi appena vaccinati che da loro il richiamo è previsto dopo 3 mesi
ma che diavoleria è questa???? Jaime, conferma? Trattasi di vaccino diverso?
Il governo ha deciso di vaccinare più gente possibile e per farlo stanno usando i vaccini, passami il termine, del richiamo
Le farmaceutiche hanno già detto che il vaccino non è stato testato con un ritardo così elevato ma BJ insiste di vaccinare più gente possibile
Son fuori di testa
ma che diavoleria è questa???? Jaime, conferma? Trattasi di vaccino diverso?
Il governo ha deciso di vaccinare più gente possibile e per farlo stanno usando i vaccini, passami il termine, del richiamo
Le farmaceutiche hanno già detto che il vaccino non è stato testato con un ritardo così elevato ma BJ insiste di vaccinare più gente possibile
Son fuori di testa
Entro 28 gg max
dove hai trovato questo dato?
io ho cercato online ma non ho trovato nessun limite massimo utile alla seconda dose, lo stesso bugiardino del vaccino si limita a dire "seconda dose dopo almeno 21 giorni"
dove hai trovato questo dato?
io ho cercato online ma non ho trovato nessun limite massimo utile alla seconda dose, lo stesso bugiardino del vaccino si limita a dire "seconda dose dopo almeno 21 giorni"
Rai1 2 giorni fa detto da un virologo in un programma che inizia alle 14. Non mi dire come si chiama perché non ricordo ora.
Avevo letto anche io tra i 21 e 28 gg
Mi sembra in un documento postato da Barros
Mi sembra in un documento postato da Barros
Rai1 2 giorni fa detto da un virologo in un programma che inizia alle 14. Non mi dire come si chiama perché non ricordo ora.
Troppi numeri in questo post XD
Troppi numeri in questo post XD
Aho sono stanco Ahahahahah, non mi vado a riguardare la puntata del programma di nuovo su RAI play ahahahahahahaha
How effective is just one dose?
A paper published in the New England Journal of Medicine stated that the efficacy of the Pfizer-BioNTech vaccine was 52.4% between the first and second dose (spaced 21 days apart).5 However, in its “green book” Public Health England said that during the phase III trial most of the vaccine failures were in the days immediately after the first dose, indicating that the short term protection starts around day 10.6 Looking at the data from day 15 to 21, it calculated that the efficacy against symptomatic covid-19 was around 89% (95% confidence interval 52% to 97%). Meanwhile, Pfizer has said that it has no evidence that the protection lasts beyond the 21 days.
In the case of the Oxford-AstraZeneca vaccine, PHE said, “High protection against hospitalisation was seen from 21 days after dose one until two weeks after the second dose, suggesting that a single dose will provide high short term protection against severe disease . . . An exploratory analysis of participants who had received one standard dose of the vaccine suggested that efficacy against symptomatic covid-19 was 73% (95% CI 48.79-85.76%).”
What do the manufacturers say?
In a joint statement Pfizer and BioNTech said, “The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design . . . There is no data to demonstrate that protection after the first dose is sustained after 21 days.”
The European Medicines Agency has said that the gap between the first and second doses of the Pfizer-BioNTech vaccine should not exceed 42 days. “Any change to this would require a variation to the marketing authorisation as well as more clinical data to support such a change, otherwise it would be considered as ‘off-label use,’” the agency said.7
AstraZeneca did not reply to a request for comment from The BMJ.
British Medical Journal
https://www.bmj.com/content/372/bmj.n18#:~:text=In%20the%20case%20of%20the,protection%20against%20severe%20disease%20.%20.%20.
A paper published in the New England Journal of Medicine stated that the efficacy of the Pfizer-BioNTech vaccine was 52.4% between the first and second dose (spaced 21 days apart).5 However, in its “green book” Public Health England said that during the phase III trial most of the vaccine failures were in the days immediately after the first dose, indicating that the short term protection starts around day 10.6 Looking at the data from day 15 to 21, it calculated that the efficacy against symptomatic covid-19 was around 89% (95% confidence interval 52% to 97%). Meanwhile, Pfizer has said that it has no evidence that the protection lasts beyond the 21 days.
In the case of the Oxford-AstraZeneca vaccine, PHE said, “High protection against hospitalisation was seen from 21 days after dose one until two weeks after the second dose, suggesting that a single dose will provide high short term protection against severe disease . . . An exploratory analysis of participants who had received one standard dose of the vaccine suggested that efficacy against symptomatic covid-19 was 73% (95% CI 48.79-85.76%).”
What do the manufacturers say?
In a joint statement Pfizer and BioNTech said, “The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design . . . There is no data to demonstrate that protection after the first dose is sustained after 21 days.”
The European Medicines Agency has said that the gap between the first and second doses of the Pfizer-BioNTech vaccine should not exceed 42 days. “Any change to this would require a variation to the marketing authorisation as well as more clinical data to support such a change, otherwise it would be considered as ‘off-label use,’” the agency said.7
AstraZeneca did not reply to a request for comment from The BMJ.
British Medical Journal
https://www.bmj.com/content/372/bmj.n18#:~:text=In%20the%20case%20of%20the,protection%20against%20severe%20disease%20.%20.%20.
L'articolo però merita di essere letto.
C'è la possibilità che la scelta sia invece ineccepibile perché dai uno shot a molte persone e abbassi la curva del contagio (e proteggi gli ospedali)
Dopo 3 mesi il secondo shot dovrebbe essere efficiente così come dopo 21 giorni
Il beneficio quindi è di abbassare il contagio e rendere l'effetto del vaccino più duraturo
C'è la possibilità che la scelta sia invece ineccepibile perché dai uno shot a molte persone e abbassi la curva del contagio (e proteggi gli ospedali)
Dopo 3 mesi il secondo shot dovrebbe essere efficiente così come dopo 21 giorni
Il beneficio quindi è di abbassare il contagio e rendere l'effetto del vaccino più duraturo